Management of Slow Intestinal Movement in Alcoholic Cirrhosis

First-Line Approach

Complete alcohol abstinence is the most critical intervention to reduce complications and mortality in alcoholic cirrhosis patients with gastroparesis, as recommended by the European Association for the Study of the Liver 1, 2

The American Association for the Study of Liver Diseases recommends implementing aggressive nutritional therapy with frequent interval feedings, emphasizing a nighttime snack and morning feeding to improve nitrogen balance in patients with alcoholic cirrhosis and gastroparesis 3, 2
Ensure adequate protein intake (1.2-1.5 g/kg/day) despite gastroparesis, as protein restriction is not recommended in alcoholic cirrhosis, according to the American Association for the Study of Liver Diseases 3
Consider enteral nutrition support if oral intake is significantly compromised due to severe gastroparesis, as suggested by the American Association for the Study of Liver Diseases 3

The European Association for the Study of the Liver recommends using caution with paracetamol in alcoholic cirrhosis patients, particularly when malnourished 1
Avoid disulfiram due to potential hepatotoxicity; consider baclofen as a safe anti-craving drug in patients with advanced liver disease, as recommended by the European Association for the Study of the Liver 1

Monitor for fluid retention and electrolyte imbalances, which can be exacerbated by both the cirrhosis and metoclopramide therapy, and start with single morning doses of oral spironolactone (100 mg) and furosemide (40 mg) if ascites is present, adjusting dosage every 7 days as needed, as recommended by the European Association for the Study of the Liver 4
Diuretic dosage should be adjusted to achieve weight loss of no more than 0.5 kg/day in patients without peripheral edema and 1 kg/day in those with peripheral edema, according to the European Association for the Study of the Liver 4
Monitor serum sodium closely, as hyponatremia may be exacerbated by diuretic therapy; consider temporarily stopping diuretics if serum sodium decreases below 120-125 mmol/L, as recommended by the European Association for the Study of the Liver 4

Patients with alcoholic cirrhosis and gastroparesis are at increased risk for bacterial infections and should be monitored closely, as suggested by the American Association for the Study of Liver Diseases 2
Hepatic encephalopathy, which has the highest mortality among complications of decompensated cirrhosis, may be precipitated by medications used to treat gastroparesis, according to the American Association for the Study of Liver Diseases 2

Perform frequent measurements of serum creatinine, sodium, and potassium during the first weeks of treatment, as recommended by the European Association for the Study of the Liver 4